Clinical Trials Logo

Clinical Trial Summary

Contrast-enhanced ultrasound (CEUS) substantially improves the potential of ultrasound (US) for the identification and characterization of focal liver lesions (FLLs). Compared to contrasted-enhanced MRI and CT, it has some unique advantages, such as the absence of ionizing radiation, and easy operability and repeatability. However, the efficacy of CEUS in diagnosing liver lesions is challenged by several factors including being highly dependent on doctor's experience, low signal-to-noise ratio, and low interobserver agreement. Therefore, it is a beneficial attempt to construct an intelligent CEUS diagnosis system using digital information technology. This study aims to collect standard data of CEUS cines recordings and develop deep learning model for accurate segmentation, detection and classification of liver lesions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04682886
Study type Observational
Source Chinese PLA General Hospital
Contact Jie Yu, Dr
Phone 15901417963
Email jiemi301@163.com
Status Recruiting
Phase
Start date January 1, 2017
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05393102 - Auxiliary Diagnosis of Liver Nodules Using cfDNA Whole-genome Signatures
Completed NCT00781924 - Interventional Sonography Guided by Image Fusion N/A
Recruiting NCT03871140 - Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis
Completed NCT00243633 - Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS) N/A